Gout in the elderly

Clinical Geriatrics

Volumn 19, Issue 1, 2011, Pages 20-25

  Ning, Tony C ^a   Keenan, Robert T ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ANTITHROMBOCYTIC AGENT; AZATHIOPRINE; BENZBROMARONE; COLCHICINE; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTROGEN; FEBUXOSTAT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IBUPROFEN; INDOMETACIN; INTERLEUKIN 1; KETOROLAC; MERCAPTOPURINE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; PROBENECID; SALICYLIC ACID; SALICYLIC ACID DERIVATIVE; SULFINPYRAZONE; THEOPHYLLINE; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; URIC ACID; URICOSURIC AGENT; WARFARIN; XANTHENE;

ABDOMINAL PAIN; ADD ON THERAPY; AGED; ALCOHOL CONSUMPTION; ANKLE; ARTHROCENTESIS; ARTHROPATHY; ARTICLE; BACTERIAL ARTHRITIS; CENTRAL NERVOUS SYSTEM DISEASE; CHILL; CLINICAL FEATURE; COMORBIDITY; COMPARATIVE STUDY; CONFUSION; DAILY LIFE ACTIVITY; DIARRHEA; DIET THERAPY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG CHOICE; DRUG CLEARANCE; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG ERUPTION; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG METABOLISM; DRUG SAFETY; DRUG USE; ECHOGRAPHY; EDEMA; ELBOW; ERYTHEMA; FEVER; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; GOLD STANDARD; GOUT; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEART FAILURE; HEPATITIS; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERURICEMIA; INFECTION; INFECTION RISK; KIDNEY CLEARANCE; KIDNEY FAILURE; KNEE; LIFESTYLE MODIFICATION; LOW DRUG DOSE; MALAISE; METATARSOPHALANGEAL JOINT; NAUSEA; NEUROMUSCULAR DISEASE; ONSET AGE; PAIN; PATHOPHYSIOLOGY; PREMENOPAUSE; PRESCRIPTION; PSEUDOGOUT; PSYCHOSIS; RHABDOMYOLYSIS; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SEX RATIO; SIDE EFFECT; SYNOVIAL FLUID; TEMPERATURE; TREATMENT PLANNING; UREA BLOOD LEVEL; URIC ACID BLOOD LEVEL; UROLITHIASIS; VASCULITIS; VOMITING; WRIST;

EID: 79951886063     PISSN: 10951598     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Saag KG, Choi H. Epidemiology, risk factors, and lifestyle modifications for gout. Arthritis Res Ther 2006;8(suppl 1):S2.
2. Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schumacher HR Jr, Sa (Pubitemid 40197509)
3. Wallace KL, Riedel AA, Joseph-Ridge N, Wortmann R. Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol 2004;31(8):1582-1587. (Pubitemid 39006641)
4. Singh JA. Quality of life and quality of care for patients with gout. Curr Rheumatol Rep 2009;11(2):154-160.
5. Pillinger MH, Keenan RT. Update on the management of hyperuricemia and gout. Bull NYU Hosp Jt Dis 2008;66(3):231-239.
6. Beyth RJ, Shorr RI. Principles of drug therapy in older patients: Rational drug prescribing. Clin Geriatr Med 2002;18(3):577-592. (Pubitemid 34966694)
7. Keenan RT, Pillinger MH. Hyperuricemia, gout, and cardiovascular disease-An important "muddle." Bull NYU Hosp Jt Dis 2009;67(3):285-290.
8. Krishnan E, Baker JF, Furst DE, Schumacher HR. Gout and the risk of acute myocardial infarction. Arthritis Rheum 2006;54(8):2688-2696. (Pubitemid 44208638)
9. Hanly JG, Skedgel C, Sketris I, et al. Gout in the elderly-A population health study. J Rheumatol 2009;36(4):822-830.
10. Wu EQ, Patel PA, Yu AP, et al. Disease-related and all-cause health care costs of elderly patients with gout. J Manag Care Pharm 2008;14(2):164-175. (Pubitemid 351453817)
11. Choi HK, Mount DB, Reginato AM; American College of Physicians; American Physiological Society. Pathogenesis of gout. Ann Intern Med 2005;143(7):499-516. (Pubitemid 41379398)
12. Becker MA, Ruoff GE. What do I need to know about gout? J Fam Pract 2010;59(6 Suppl):S1-S8.
13. Terkeltaub R. Epidemiology, pathology, and pathogenesis. In: Klippel J, ed. Primer on the Rheumatic Diseases 12th ed. Atlanta, GA: Arthritis Foundation; 2001:307-312.
14. Fam AG. Gout in the elderly. Clinical presentation and treatment. Drugs Aging 1998;13(3):229-243. (Pubitemid 28461783)
15. Shmerling RH. Synovial fluid analysis. A critical reappraisal. Rheum Dis Clin North Am 1994;20(2):503-512. (Pubitemid 24163462)
16. Yu KH, Luo SF, Liou LB, et al. Concomitant septic and gouty arthritis-An analysis of 30 cases. Rheumatology (Oxford) 2003;42(9):1062-1066. Published Online: April 16, 2003. (Pubitemid 37220994)
17. Fam AG, Stein J, Rubenstein J. Gouty arthritis in nodal osteoarthritis. J Rheumatol 1996;23(4):684-689. (Pubitemid 26132854)
18. Maccagno A. Di Giorgio E, Romanowicz A. Effectiveness of etodolac ("Lodine") compared with naproxen in patients with acute gout. Curr Med Res Opin 1991;12(7):423-429.
19. Smyth CJ, Percy JS. Comparison of indomethacin and phenylbutazone in acute gout. Ann Rheum Dis 1973;32(4):351-353.
20. Shrestha M, Morgan DL, Moreden JM, Singh R, Nelson M, Hayes JE. Randomized double-blind comparison of the analgesic efficacy of intramuscular ketorolac and oral indomethacin in the treatment of acute gouty arthritis. Ann Emerg Med 1995;26(6):682-686.
21. Altman RD, Honig S, Levin JM, Lightfoot RW. Ketoprofen versus indomethacin in patients with acute gouty arthritis: A multicenter, double blind comparative study. J Rheumatol 1988;15(9):1422-1426.
22. Schumacher HR Jr, Boice JA, Daikh DI, et al. Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis. BMJ 2002;324(7352): 1488-1492. (Pubitemid 34666615)
23. Hoskison KT, Wortmann RL. Management of gout in older adults: Barriers to optimal control. Drugs Aging 2007;24(1):21-36. (Pubitemid 46148079)
24. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: Results of a U.S. consensus panel of experts [published correction appears in Arch Intern Med 2004;164(3):298]. Arch Intern Med 2003;163(22):2716-2724. (Pubitemid 37517412)
25. Butler JM, Begg EJ. Free drug metabolic clearance in elderly people. Clin Pharmacokinet 2008;47(5):297-321. (Pubitemid 351508117)
26. Kuncl RW, Duncan G, Watson D, Alderson K, Rogawski MA, Peper M. Colchicine myopathy and neuropathy. N Engl J Med 1987;316(25):1562-1568. (Pubitemid 17083593)
27. Sahin G, Korkmaz C, Yalcin AU. Which statin should be used together with colchicine? Clinical experience in three patients with nephrotic syndrome due to AA type amyloidosis. Rheumatol Int 2008;28(3):289-291. Published Online: August 17, 2007. (Pubitemid 350265477)
28. Terkeltaub RA, Furst DE, Bennett K, Kook KA, Crockett RS, Davis MW. High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel- group, dose-comparison colchicine study. Arthritis Rheum 2010;62(4):1060-1068.
29. Hanlon JT, Aspinall SL, Semla TP, et al. Consensus guidelines for oral dosing of primarily renally cleared medications in older adults [published correction appears in J Am Geriatr Soc 2009;57(11):2179]. J Am Geriatr Soc 2009;57(2):335-340. Published Online: December 10, 2008.
30. Perez-Ruiz F, Calabozo M, Pijoan JI, Herrero-Beites AM, Ruibal A. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout. Arthritis Rheum 2002;47(4):356-360. (Pubitemid 34856121)
31. Jordan KM, Cameron JS, Snaith M, et al; British Society for Rheumatology and British Health Professionals in Rheumatology Standards, Guidelines and Audit Working Group (SGAWG). British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout. Rheumatology (Oxford) 2007;46(8):1372-1374. Published Online: May 23, 2007.
32. Terkeltaub RA. Clinical practice. Gout. N Engl J Med 2003;349(17):1647- 1655.
33. Singer JZ, Wallace SL. The allopurinol hypersensitivity syndrome. Unnecessary morbidity and mortality. Arthritis Rheum 1986;29(1):82-87. (Pubitemid 17015410)
34. Vázquez-Mellado J, Morales EM, Pacheco-Tena C, Burgos-Vargas R. Relation between adverse events associated with allopurinol and renal function in patients with gout. Ann Rheum Dis 2001;60(10):981-983. (Pubitemid 32885676)
35. Dalbeth N, Kumar S, Stamp L, Gow P. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout. J Rheumatol 2006;33(8):1646-1650. (Pubitemid 44168841)
36. Reinders MK, van Roon EN, Jansen TL, et al. Efficacy and tolerability of urate-lowering drugs in gout: A randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol. Ann Rheum Dis 2009;68(1):51-56. Published Online: February 4, 2008.
37. Khosravan R, Grabowski B, Wu JT, Joseph-Ridge N, Vernillet L. Effect of food or antacid on pharmacokinetics and pharmacodynamics of febuxostat in healthy subjects. Br J Clin Pharmacol 2008;65(3):355-363. Published Online: October 22, 2007. (Pubitemid 351316909)
38. Mayer MD, Khosravan R, Vernillet L, Wu JT, Joseph-Ridge N, Mulford DJ. Pharmacokinetics and pharmacodynamics of febuxostat, a new non-purine selective inhibitor of xanthine oxidase in subjects with renal impairment. Am J Ther 2005; 12(1):22-34. (Pubitemid 40516043)
39. Khosravan R, Kukulka MJ, Wu JT, Joseph-Ridge N, Vernillet L. The effect of age and gender on pharmacokinetics, pharmacodynamics, and safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase. J Clin Pharmacol 2008;48(9):1014-1024. Published Online: July 17, 2008.
40. Becker MA, Schumacher HR Jr, Wortmann RL, et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med 2005;353(23):2450-2461. (Pubitemid 41781828)
41. Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Alcohol intake and risk of incident gout in men: A prospective study. Lancet 2004;363(9417):1277- 1281. (Pubitemid 38496489)
42. Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004;350(11):1093-1103. (Pubitemid 38298989)
43. Levinson W, Cohen MS, Brady D, Duffy FD. To change or not to change: "Sounds like you have a dilemma." Ann Intern Med 2001;135(5):386-391. (Pubitemid 32823249)